Literature DB >> 31452157

Measuring Cryptosporidium Serologic Responses by Multiplex Bead Assay.

Jeffrey W Priest1, Delynn M Moss2.   

Abstract

For more than 35 years, various assay formats have been used to detect Cryptosporidium-specific antibodies in human and animal sera. Cryptosporidium parvum 17- and 27-kDa antigens, identified from invasive sporozoites, have been used in serologic antibody assays to identify individuals infected in outbreaks of diarrheal disease caused by this protozoan parasite and to monitor exposures in communities. During infection, immunoglobulin (Ig) A, IgM, and IgG responses are elicited by these immunodominant antigens, and the parasite-specific Ig responses diminish following the resolution of infection. Using the recombinant forms of the 17- and 27-kDa C. parvum antigens and the relatively recently developed multiplex bead assay (MBA), data from serologic antibody responses can be economically and efficiently acquired, especially when the Cryptosporidium assays are integrated with assays for antibody responses to antigens from other pathogens monitored in community-wide or nation-wide serosurveys. Here we describe the coupling of the C. parvum recombinant antigens to carboxylated polystyrene beads, the data acquisition and analysis of IgG antibodies bound to the coupled beads, and the quality control methods required for data validation using the Luminex/MBA system.

Entities:  

Keywords:  17-kDa antigen; 27-kDa antigen; Cryptosporidium; Immunoglobulin G responses; Multiplex bead assay

Year:  2020        PMID: 31452157     DOI: 10.1007/978-1-4939-9748-0_5

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

2.  Adaptation to a Multiplex Bead Assay and Seroprevalence to Rift Valley Fever N Protein: Nampula Province, Mozambique, 2013-2014.

Authors:  Eric Rogier; Mateusz Plucinski; Baltazar Candrinho; Delynn M Moss; Aridth Gibbons; James Colborn; Jeffrey Higgins; Geraldo Chambe; Joao Muchanga; Olinda Muguande; Graca Matsinhe; Guidion Mathe; Timothy Doyle; Rose Zulliger; Abu Saifodine; Joel M Montgomery; John D Klena; Jeffrey W Priest
Journal:  J Virol       Date:  2022-07-27       Impact factor: 6.549

3.  Seroprevalence of antibodies against Chlamydia trachomatis and enteropathogens and distance to the nearest water source among young children in the Amhara Region of Ethiopia.

Authors:  Kristen Aiemjoy; Solomon Aragie; Dionna M Wittberg; Zerihun Tadesse; E Kelly Callahan; Sarah Gwyn; Diana Martin; Jeremy D Keenan; Benjamin F Arnold
Journal:  PLoS Negl Trop Dis       Date:  2020-09-02

4.  Development of a Multiplex Bead Assay for the Detection of IgG Antibody Responses to Guinea Worm.

Authors:  Jeffrey W Priest; Olga Stuchlik; Matthew Reed; Peter Soboslay; Vitaliano Cama; Sharon L Roy
Journal:  Am J Trop Med Hyg       Date:  2020-09-03       Impact factor: 3.707

5.  Performance of SARS-CoV-2 Antigens in a Multiplex Bead Assay for Integrated Serological Surveillance of Neglected Tropical and Other Diseases.

Authors:  Sarah Gwyn; Ado Abubakar; Oluwaseun Akinmulero; Eric Bergeron; Ugboaja Nkechi Blessing; Jasmine Chaitram; Melissa M Coughlin; Ayuba B Dawurung; Felicia Nwatu Dickson; Mudiaga Esiekpe; Erasogie Evbuomwan; Stacie M Greby; Nnaemeka C Iriemenam; Markus H Kainulainen; Thomas Andrew Naanpoen; Loveth Napoloen; Ifeanyichukwu Odoh; McPaul Okoye; Temitope Olaleye; Amy J Schuh; S Michele Owen; Awala Samuel; Diana L Martin
Journal:  Am J Trop Med Hyg       Date:  2022-06-27       Impact factor: 3.707

6.  Precision of Serologic Testing from Dried Blood Spots Using a Multiplex Bead Assay.

Authors:  Sarah Gwyn; Solomon Aragie; Dionna M Wittberg; Jason S Melo; Adane Dagnew; Dagnachew Hailu; Zerihun Tadesse; Mahteme Haile; Taye Zeru; Scott D Nash; Benjamin F Arnold; Diana L Martin; Jeremy D Keenan
Journal:  Am J Trop Med Hyg       Date:  2021-07-12       Impact factor: 3.707

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.